COFCO Biotechnology Co., Ltd. (000930) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

COFCO Biotechnology Co., Ltd.

Why is COFCO Biotechnology Co., Ltd. ?

High Debt Company with a Debt to Equity ratio (avg) at times

Poor long term growth as Net Sales has grown by an annual rate of -1.47% and Operating profit at -49.86% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times
The company has been able to generate a Return on Equity (avg) of 4.87% signifying low profitability per unit of shareholders funds

Poor long term growth as Net Sales has grown by an annual rate of -1.47% and Operating profit at -49.86% over the last 5 years

The company has declared Positive results for the last 4 consecutive quarters

OPERATING CASH FLOW(Y) Highest at CNY 1,275.55 MM
NET PROFIT(HY) At CNY 35.95 MM has Grown at 73.52%
ROCE(HY) Highest at 0.89%

With ROE of 0.79%, it has a attractive valuation with a 1.03 Price to Book Value

Over the past year, while the stock has generated a return of 19.00%, its profits have risen by 146.7% ; the PEG ratio of the company is 0.9

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to COFCO Biotechnology Co., Ltd. should be less than 10%
Overall Portfolio exposure to Specialty Chemicals should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is COFCO Biotechnology Co., Ltd. for you?

Medium Risk, Medium Return

Absolute

Risk Adjusted

Volatility

COFCO Biotechnology Co., Ltd.

20.79%

0.47

26.13%

China Shanghai Composite

13.33%

0.90

14.74%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-1.47%

EBIT Growth (5y)

-49.86%

EBIT to Interest (avg)

4.55

Debt to EBITDA (avg)

175.16

Net Debt to Equity (avg)

0.29

Sales to Capital Employed (avg)

1.31

Tax Ratio

54.14%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

4.00%

ROE (avg)

4.87%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

129

Industry P/E

Price to Book Value

1.03

EV to EBIT

155.84

EV to EBITDA

20.99

EV to Capital Employed

1.02

EV to Sales

0.69

PEG Ratio

0.88

Dividend Yield

ROCE (Latest)

0.66%

ROE (Latest)

0.79%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 1,275.55 MM

NET PROFIT(HY)

At CNY 35.95 MM has Grown at 73.52%

ROCE(HY)

Highest at 0.89%

RAW MATERIAL COST(Y)

Fallen by -19.65% (YoY

CASH AND EQV(HY)

Highest at CNY 4,906.04 MM

DEBT-EQUITY RATIO (HY)

Lowest at 15.55 %

INVENTORY TURNOVER RATIO(HY)

Highest at 7.74 times

-14What is not working for the Company

NET SALES(HY)

At CNY 8,876.19 MM has Grown at -14.17%

PRE-TAX PROFIT(Q)

At CNY -6.5 MM has Fallen at -118.27%

OPERATING PROFIT(Q)

Lowest at CNY -52.29 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -1.18 %

NET PROFIT(Q)

Lowest at CNY -21.41 MM

Here's what is working for COFCO Biotechnology Co., Ltd.

Operating Cash Flow

Highest at CNY 1,275.55 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Cash and Eqv

Highest at CNY 4,906.04 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio

Lowest at 15.55 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Inventory Turnover Ratio

Highest at 7.74 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -19.65% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for COFCO Biotechnology Co., Ltd.

Pre-Tax Profit

At CNY -6.5 MM has Fallen at -118.27%

over average net sales of the previous four periods of CNY 35.57 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY -21.41 MM has Fallen at -228.24%

over average net sales of the previous four periods of CNY 16.7 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Net Sales

At CNY 8,876.19 MM has Grown at -14.17%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY -52.29 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at -1.18 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Net Profit

Lowest at CNY -21.41 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)